alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › anti-amyloid-antibody

anti-amyloid-antibody

4 studies tagged anti-amyloid-antibody, dated 2023-09-11 to 2026-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brain 2026-04-01
  2. Monoclonal anti-amyloid antibody treatment: the epidemiological profile of the target patients in Austria and the status of treatment-eligible patients registered at an outpatient memory clinic 2024-10-23
  3. [Anti-amyloid Antibody Drugs as Disease-Modifying Therapies for Alzheimer's Disease] 2024-09-01

Studies

4 studies carry this tag.

Date range

2023 to 2026

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Brain and nerve = Shinkei kenkyu no shinpo 1
  • European journal of neurology 1
  • Wiener klinische Wochenschrift 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brain

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2026-04-01 Treatments

    Lecanemab's binding target is similar to other antibodies'.

  2. Monoclonal anti-amyloid antibody treatment: the epidemiological profile of the target patients in Austria and the status of treatment-eligible patients registered at an outpatient memory clinic

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Wiener klinische Wochenschrift 2024-10-23 Treatments

    The development of monoclonal anti-amyloid antibodies, a disease-modifying treatment for Alzheimer's disease (AD), has raised the necessity to identify the epidemiological profile of the possible target patients who would benefit from such therapy.

  3. [Anti-amyloid Antibody Drugs as Disease-Modifying Therapies for Alzheimer's Disease]

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Brain and nerve = Shinkei kenkyu no shinpo 2024-09-01 Treatments

    Alzheimer's disease (AD) is a common dementia disorder in the elderly individuals, accounting for approximately 60-70% of all dementia cases.

  4. Anti-amyloid antibody treatments for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. European journal of neurology 2023-09-11 Treatments

    Our aim is to review the most recent evidence on novel antibody therapies for Alzheimer's disease directed against amyloid-β.

All topic tags with their study counts